Article
Author(s):
The American Academy of Ophthalmology's (AAO) 2-year effort to convince Medicare to adopt a national coverage policy for low-vision rehabilitation services has finally paid off.
Survey reveals gaps in patient awareness of preservative-free glaucoma treatments
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Choroidal vascularity index offers insight into eye health after COVID-19 recovery
FDA accepts new drug application for low-dose atropine from Sydnexis